Bioqual, Inc.
BIOQ · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.25 | 0.93 | -0.08 | -0.16 |
| FCF Yield | 0.00% | 15.50% | 0.48% | -3.53% |
| EV / EBITDA | 29.67 | 80.34 | 31.53 | -54.41 |
| Quality | ||||
| ROIC | -0.73% | 0.82% | 1.49% | -2.47% |
| Gross Margin | 8.88% | -42.44% | 19.47% | -1.00% |
| Cash Conversion Ratio | -63.67 | 0.29 | 1.74 | 2.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.06% | -7.95% | -8.96% | -9.54% |
| Free Cash Flow Growth | 0.00% | 2,264.16% | 112.21% | -36.03% |
| Safety | ||||
| Net Debt / EBITDA | -2.81 | -2.76 | 3.07 | -5.45 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 87.62 | 91.26 | 100.17 | 113.52 |